Why the study?
ACS poses a major global disease burden with high morbidity and mortality, prompting an assessment of clinical pharmacy interventions to improve quality use of medicines and drug-related problems.
Does a clinical pharmacy intervention improve medication adherence in patients with acute coronary syndrome?
Comparison
Clinical pharmacy interventions for six months vs control
Design
Single-centre open prospective controlled nonrandomised clinical trial
Follow-up
6 months
Authors
Loading...
May support pharmacist-led adherence programs in ACS; leaves open need for RCTs to confirm causality before practice change.
Does a clinical pharmacy intervention improve medication adherence in patients with acute coronary syndrome?
Clinical pharmacist-led interventions significantly improve medication adherence and discharge medication appropriateness in patients with acute coronary syndrome.
Bagyawantha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: